Categories: News

Cannalogue Expands Compassionate Care Program to Provide Lowest Medical Cannabis Price in Canada

Starting 4/20, online medical CBD supplier will offer dried flower at $1.96/gram

TORONTO, April 07, 2021 (GLOBE NEWSWIRE) — Doctor recommended medical CBD supplier, Cannalogue, has announced a significant price reduction for medical cannabis patients across Canada. As part of its expanded Compassionate Care Program, Cannalogue has secured the lowest per gram price for medical cannabis in Canada at $1.96/gram. Additionally, eligible new patients will receive 20% off their first order upon completion of a medical assessment.

With the most inclusive qualification criteria in Canada, Cannalogue’s Compassionate Care Program provides discounts of 20-50% on a wide range of medical cannabis products such as dried flower, oils, capsules, and topicals. Qualified groups include frontline workers, seniors (aged 60+), veterans, Indigenous peoples, first responders, nurses, teachers, those facing financial strain due to COVID-19 work shortage/layoffs, individuals currently enrolled in a disability, federal or provincial assistance program, and individuals with annual incomes less than $70,000 per year.

“We are living in times of unprecedented financial need, where cost is the key determinant in health decisions,” says Cannalogue President and CEO, Dr. Mohan Cooray. “With the lack of reasonable coverage, Cannalogue is doing all that we can to help our patients, and today is a gigantic leap forward in the quest towards affordable medical cannabis access for all Canadians,” he says.

To learn more about Cannalogue’s COVID-19 Compassionate Care Program or to enroll, visit www.cannalogue.ca/compassionate-care

About Cannalogue:
Based in Toronto, Cannalogue is a rapidly emerging global healthcare technology company that received Health Canada’s first direct-to-sales licence for medical cannabis. Cannalogue’s innovative technology provides a safe, controlled, and cost-effective online marketplace that is globally scalable into all medical cannabis markets.  Engineered by physicians, Cannalogue challenges the status quo and advocates on behalf of patients to educate medical professionals and government officials on the safety and benefits of medical cannabis as a viable treatment option to traditional therapies.

 

CONTACT: Media Contact:

Melanie Greco
Public Relations
647-456-2653
melanie.greco@cannalogue.ca

Staff

Recent Posts

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP)…

12 hours ago

InsiteOne Achieves Strong Growth with Six New Contracts Post Acquisition of BRIT Systems Cloud-Native RIS/PACS/VNA

WALLINGFORD, Conn., June 18, 2024 /PRNewswire/ -- InsiteOne, a leading provider of cloud-based Vendor Neutral Archive…

12 hours ago

Young Women’s Christian Association of Bethlehem PA Completes its Investigation of Security Incident

BETHLEHEM, Pa., June 18, 2024 /PRNewswire/ -- Young Women's Christian Association of Bethlehem PA ("YWCA…

12 hours ago

INSIGHTEC ANNOUNCES $150M FINANCING TO FUND CONTINUED GROWTH

Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead…

12 hours ago

IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution

Combined entity delivers the ICyte® revenue optimization platform powered by first-party data, AI-enabled data exploration,…

12 hours ago

WellBe Senior Medical Earns HITRUST & NIST Certification, Highlighting Commitment to Data Security

CHICAGO, June 18, 2024 /PRNewswire/ -- WellBe Senior Medical and its affiliated medical groups announce…

12 hours ago